Guilin Sanjin Pharmaceutical Co Ltd Capital Reinvestment Ratio
Guilin Sanjin Pharmaceutical Co Ltd capital reinvestment ratio. Guilin Sanjin Pharmaceutical Co Ltd (002275) has a Capital Reinvestment Ratio of 1.06x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥117.62 Million) in capital expenditures (CN¥124.26 Million). See Guilin Sanjin Pharmaceutical Co Ltd (002275) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Guilin Sanjin Pharmaceutical Co Ltd (2006–2024)
Capital reinvestment ratio of Guilin Sanjin Pharmaceutical Co Ltd from 2006 to 2024. This chart tracks Guilin Sanjin Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 19 annual periods. See financial agility of Guilin Sanjin Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
Guilin Sanjin Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2006–2024)
Guilin Sanjin Pharmaceutical Co Ltd capital reinvestment ratio by year from 2006 to 2024. For the full cash flow conversion analysis, see Guilin Sanjin Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.14x | CN¥588.33 Million | CN¥82.18 Million | ▲ +0.4% |
| 2023 | 0.14x | CN¥549.25 Million | CN¥76.40 Million | ▲ +18.1% |
| 2022 | 0.12x | CN¥528.67 Million | CN¥62.27 Million | ▼ -66.5% |
| 2021 | 0.35x | CN¥410.24 Million | CN¥144.09 Million | ▲ +2.2% |
| 2020 | 0.34x | CN¥597.99 Million | CN¥205.47 Million | ▼ -28.8% |
| 2019 | 0.48x | CN¥468.29 Million | CN¥226.14 Million | ▲ +196.2% |
| 2018 | 0.16x | CN¥551.73 Million | CN¥89.96 Million | ▲ +2.8% |
| 2017 | 0.16x | CN¥387.82 Million | CN¥61.53 Million | ▲ +30.3% |
| 2016 | 0.12x | CN¥536.85 Million | CN¥65.36 Million | ▼ -61.2% |
| 2015 | 0.31x | CN¥398.50 Million | CN¥125.02 Million | ▼ -41.1% |
| 2014 | 0.53x | CN¥396.53 Million | CN¥211.28 Million | ▼ -46.5% |
| 2013 | 1.00x | CN¥314.16 Million | CN¥312.85 Million | ▲ +46.5% |
| 2012 | 0.68x | CN¥302.59 Million | CN¥205.63 Million | ▲ +82.9% |
| 2011 | 0.37x | CN¥341.05 Million | CN¥126.75 Million | ▲ +7.8% |
| 2010 | 0.34x | CN¥285.49 Million | CN¥98.44 Million | ▲ +129.1% |
| 2009 | 0.15x | CN¥363.29 Million | CN¥54.68 Million | ▼ -25.6% |
| 2008 | 0.20x | CN¥190.97 Million | CN¥38.64 Million | ▲ +89.1% |
| 2007 | 0.11x | CN¥164.39 Million | CN¥17.59 Million | ▼ -20.1% |
| 2006 | 0.13x | CN¥217.67 Million | CN¥29.16 Million | — |